Author: Kaesemeyer, Wayne; Suvorava, Tatsiana
Title: Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione Cord-id: lr1b2s9f Document date: 2021_3_22
ID: lr1b2s9f
Snippet: The purpose of this current opinion article is to illustrate a novel approach to the treatment of acute decompensated heart failure (ADHF) in coronavirus disease 2019 (COVID-19) patients. The approach described herein relies on a reformulation of intravenous nitroglycerin in 5% glutathione, itself novel, and is felt to have the potential to not only improve the rate of resolution of ADHF, but also reduce the risk of complications of heart failure seen in patients with COVID-19.
Document: The purpose of this current opinion article is to illustrate a novel approach to the treatment of acute decompensated heart failure (ADHF) in coronavirus disease 2019 (COVID-19) patients. The approach described herein relies on a reformulation of intravenous nitroglycerin in 5% glutathione, itself novel, and is felt to have the potential to not only improve the rate of resolution of ADHF, but also reduce the risk of complications of heart failure seen in patients with COVID-19.
Search related documents:
Co phrase search for related documents- acute adhf decompensated heart failure and adhf decompensated heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute adhf decompensated heart failure and adhf incidence: 1
- acute ards respiratory distress syndrome and adenine nadph dinucleotide phosphate: 1
Co phrase search for related documents, hyperlinks ordered by date